Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Malik Kahook to Intravitreal Injections

This is a "connection" page, showing publications Malik Kahook has written about Intravitreal Injections.

 
Connection Strength
 
 
 
0.488
 
  1. SooHoo JR, Seibold LK, Pantcheva MB, Kahook MY. Aflibercept for the treatment of neovascular glaucoma. Clin Exp Ophthalmol. 2015 Dec; 43(9):803-7.
    View in: PubMed
    Score: 0.119
  2. SooHoo JR, Seibold LK, Kahook MY. The link between intravitreal antivascular endothelial growth factor injections and glaucoma. Curr Opin Ophthalmol. 2014 Mar; 25(2):127-33.
    View in: PubMed
    Score: 0.108
  3. Khandan O, Famili A, Kahook MY, Rao MP. Titanium-based, fenestrated, in-plane microneedles for passive ocular drug delivery. Annu Int Conf IEEE Eng Med Biol Soc. 2012; 2012:6572-5.
    View in: PubMed
    Score: 0.093
  4. Good TJ, Kimura AE, Mandava N, Kahook MY. Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents. Br J Ophthalmol. 2011 Aug; 95(8):1111-4.
    View in: PubMed
    Score: 0.085
  5. Levin AM, Chaya CJ, Kahook MY, Wirostko BM. Intraocular Pressure Elevation Following Intravitreal Anti-VEGF Injections: Short- and Long-term Considerations. J Glaucoma. 2021 12 01; 30(12):1019-1026.
    View in: PubMed
    Score: 0.046
  6. Torres JA, Fischer NA, Seibold LK, Pantcheva MB, Kahook MY, SooHoo JR. A Survey of Patient Perceptions and Preferences for Glaucoma Treatment with Intravitreal Injections. Ophthalmol Glaucoma. 2018 Jul - Aug; 1(1):61-65.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)